Osteoporosis in Primary Hyperparathyroidism
NCT04085419
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Primary Hyperparathyroidism
Osteoporosis
Interventions
DRUG:
Denosumab 60 MG/ML Prefilled Syringe [Prolia]
DRUG:
Zoledronic Acid
Sponsor
University Medical Centre Ljubljana